Investor Relations


Corporate Profile

At Camlin Fine Sciences, in line with our vision 'to be the globally preferred, trusted and integrated provider of reliable and innovative antioxidant solutions, aroma ingredients and performance chemicals'...we see the world as our market.

We have been providing products & servicing customers locally and across continents for more than 25 years.

The power of integration has given us unmatched advantages of size, scale and scope and catapulted us to a premier position as one of the world's leading producers and exporters of Food Grade antioxidants TBHQ & BHA, with over 45% market share globally.

Our Aroma Ingredients comprise of Vanillin and Ethyl Vanillin. Vanillin, as we all know, is the largest and most popular flavouring compound in the world.

We have been successful in our Performance Chemicals Division with Catechol and Hydroquinone downstream products like Guaiacol, Veratrol, TBC, MEHQ etc. serving the Petrochemical, Pharmaceutical, and Agrochemicals Industries worldwide.


STRATEGIC INITIATIVES:

Highlights 2015:
  • CFS North America LLC has been set-up in USA for undertaking the production and marketing of unique antioxidant blends for the food, feed, pet food, aroma ingredient and performance chemicals markets in the USA and Canada.
  • CFS ANTIOXIDANTES DE MEXICO S.A. DE C.V. has been set-up in Mexico for marketing and sales of unique antioxidant blends for the food, feed, pet food, aroma ingredient and performance chemicals in Mexico and Central American markets.
  • Our Sales team in Europe is fully equipped to serve your Shelf Life Solution needs.

Journey Ahead:

  • Planned our new manufacturing facility at Dahej SEZ, India.
  • Our subsidiary CFS ANTIOXIDANTES DE MEXICO S.A. DE C.V., Mexico has acquired 65 % stake in DRESEN QUIMICA S.A.P.I.de C.V., Mexico along with its group companies and subsidiaries.
  • In July 2017, with acquisition of 51% stake in Ningbo Wanglong Flavors & Fragrances Company Ltd., China, CFS became the 3rd largest producer of Vanillin in the world.














Annual Reports

Unclaimed Dividends

Placement Document

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED IN THE UNITED STATES. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY CAMLIN FINE SCIENCES LIMITED (THE “COMPANY”) TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2009, AS AMENDED (“SEBI REGULATIONS”).

Please read this notice carefully as it applies to all persons who view this site.

The materials placed herein are so placed pursuant to the SEBI Regulations and are not intended to nor constitute an invitation to subscribe or a solicitation to offer to subscribe to the securities referred therein. Unless a pre-numbered placement document accompanied by an application form is addressed to a specific person inviting such person to make a bid through such application form, no offer and/or invitation of offer shall be deemed to have been made.

Viewing this information may not be lawful in certain jurisdictions. Only persons located outside the United States may view this information.

Unless otherwise determined by the Company and permitted by applicable law and regulation, it is not intended that any offering of securities by the Company would be made directly or indirectly, in or into, the United States, except pursuant to an exemption from or in a transaction not subject to registration as described below.

The securities being referred to herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or any U.S. state securities laws. Accordingly, subject to certain exceptions, such securities may not be offered, sold or otherwise transferred in or into the United States. The information and document contained behind these screens should not be viewed by any persons resident or physically located in the United States.

The placement referred to herein is being made in reliance upon the SEBI Regulations and section 42 of the Companies Act, 2013 and the rules made thereunder and is meant only for eligible qualified institutional buyers (i.e. “a qualified institutional buyer” as defined in Regulation 2(1)(zd) of the SEBI Regulations, other than foreign venture capital investors and international multilateral and bilateral development financial institutions, and not otherwise excluded pursuant to Regulation 86(1)(b) of the SEBI Regulations) on a private placement basis and is not an offer to the public or to any other class of investors to sell, solicit or recommend the sale or purchase of securities. The public cannot subscribe to the issue since it is a private placement.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

Continue

To access this information, you must confirm by pressing on the button marked "I Confirm" that, at the time of access you are not located inside the United States. If you cannot make this confirmation, you must press the button marked "I Do Not Confirm".

By clicking on "I confirm", you are further confirming that you shall not base any investment decision on the information contained herein and you agree that the information contained herein is not an offer to the public or to any other class of investors.

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including, without restriction, India.


I Confirm I Do Not Confirm


Website Designed & developed by Mind Square